Clinical Trials Logo

Clinical Trial Summary

Alopecia areata (AA) is a common, idiopathic and sometimes recurrent non-scarring type of hair loss.

Several etiological factors, including psychological, trauma-related, genetic and autoimmune factors have been considered as possible etiological factors . A T cell-mediated autoimmune mechanism in genetically vulnerable individuals is the most acceptable etiology.

Alopecia areata presents clinically with well demarcated patches of non cicatricial hair loss in any hair bearing area with no remarkable gender preference.

Although AA may occur at any age, incidence is high among younger age groups. In fact, it is the most common form of alopecia seen in children. Various clinical patterns of alopecia have been described as patchy, diffuse, reticulate, ophiasis and ophiasis inversus. Depending on the extent of hair loss, it can be classified into alopecia subtotalis, alopecia totalis (complete loss of scalp hair), and alopecia universalis (complete loss of body hair).

National Alopecia Areata Foundation has devised "Severity of Alopecia Tool Score" (SALT score) as a measure of disease severity. Scalp is divided into 4 areas, namely, Vertex-40% of scalp surface area; right and left profiles-18% each and posterior scalp aspect-24%. SALT score is the sum of percentage of hair loss in the above mentioned areas.


Clinical Trial Description

Alopecia areata is now considered a systemic autoimmune disease that may have other serious comorbidities, such as cardiovascular and ocular. However, the results of studies of ocular findings in AA are controversial.

Several ocular alterations have been previously reported in patients with AA ranging from minor punctate opacities to cataract. However, there are contrasting opinions on the significance of these lenticular changes. In addition, Horner syndrome, pupil ectopia, iris atrophy, fundus changes , bilateral keratoconus, iris changes and retinal changes have been reported in AA.

Dermoscopy is a noninvasive, diagnostic tool which visualizes subtle patterns of skin lesions not normally visible to the unaided eye. Characteristic dermoscopic finding of AA included black dots , tapering hair corresponding to " exclamation mark hairs " , broken hairs , yellow dots , and clustered short vellus hairs ( shorter than 10 mm).

Since ocular affection can be a profound morbidity factor in patients with AA, we will search deeply in this study about this correlation in order to conclude the value of ocular screening in each and every patient with AA. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03155958
Study type Observational
Source Assiut University
Contact Eman Riad, MD
Phone 00201005298992
Email E_raid@aun.edu.eg
Status Not yet recruiting
Phase N/A
Start date July 1, 2017
Completion date January 1, 2020

See also
  Status Clinical Trial Phase
Withdrawn NCT05019066 - Oral Herbal Combination Formulation and Hair Growth in Women N/A
Recruiting NCT05502796 - Natural History and Pathogenesis of Alopecia in Children and Adults
Completed NCT00981461 - Treatment of Androgenetic Alopecia in Females, 9 Beam N/A
Terminated NCT03709563 - Oral Nutraceutical Supplement With Standardized Botanicals in Males With Self-Perceived Thinning Hair and Loss N/A
Completed NCT06095739 - Study to Investigate the Effectiveness of a Topical Cosmetic Formulation DA-OTC-002 N/A
Completed NCT03351322 - ENERGI-F701 for Female Hair Loss Treatment Phase 2
Not yet recruiting NCT06215469 - Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads) N/A
Completed NCT05945979 - Evaluation of the Efficacy of a New Supplement for Hair and Nails - in Vitro, Clinical, Subjective and Instrumental Study N/A
Not yet recruiting NCT05484973 - Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss N/A
Recruiting NCT05319444 - Cleansing Device for the Treatment of Scalp and Hair Conditions N/A
Completed NCT06120933 - A Single-Group Clinical Trial Investigating the Effects of a Hair Vitamin Combination on Hair Growth and Hair Health N/A
Withdrawn NCT04379583 - HairDx Analytical Validation Study
Recruiting NCT05970809 - Assessing the Safety and Efficacy of a Novel Microneedling and Laser Device for Male Pattern Hair Loss N/A
Completed NCT00947219 - Treatment of Androgenic Alopecia in Males N/A
Enrolling by invitation NCT06174441 - The Effect of 24-week Dietary Intake of Food Supplements on Hair N/A
Unknown status NCT02393040 - Study to Assess Efficacy of Platelet-Rich Plasma in Androgenetic Alopecia N/A
Completed NCT01016964 - Treatment of Androgenetic Alopecia in Females, 12 Beam N/A
Recruiting NCT06283316 - Systemic Treatments for Alopecia Areata Registry
Completed NCT04249128 - Nourishing Hair, Skin & Nails Supplement Study (Derm Aid) Phase 3
Recruiting NCT06117293 - Safety and Efficacy Evaluation of the Mosaic Ultra Device N/A